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The study of channel modulation by regulatory subunits has attracted 
considerable attention. Evidence indi-
cates a pivotal role for accessory pro-
teins in the channelosome. For instance, 
these regulatory subunits are necessary 
to recapitulate in vivo ion currents and 
to further understand the physiological 
role of ion channels. KCNEs are a fam-
ily of regulatory subunits that interact 
with a wide range of channels. We have 
described for the first time a molecular 
interaction between KCNE4 and the 
voltage-dependent potassium channel 
K
V
1.3. The association of KCNE4, which 
alters the biophysical properties, traffick-
ing and membrane localization of K
V
1.3, 
functions as an endogenous dominant-
negative mechanism. Since both proteins 
are expressed in the immune system, 
K
V
1.3/KCNE4 channels may contrib-
ute to the fine-tuning of the immune 
response. Therefore, our results point 
to KCNE4 as a novel target for immu-
nomodulation. KCNE4 is not the only 
KCNE which is expressed in leukocytes. 
All KCNEs (KCNE1-5) are present, and 
some members demonstrate modulation 
during proliferation and cancer. In sum-
mary, regulatory KCNE subunits are 
expressed in the immune system. In addi-
tion, several voltage-dependent K+ chan-
nels, which could interact with KCNEs, 
are also detected. Therefore, KCNE sub-
units may play a yet undiscovered role in 
the physiology of the immune system.
KCNEs are a group of regulatory subunits 
composed of 5 members (KCNE1-5). 
KCNE peptides are small single spanning 
membrane proteins (<20 KDa) which 
modulate a large number of voltage-depen-
dent K+ channels.1 The most well charac-






nels recapitulate the cardiac I
ks
 current.5 
Several KCNE1 mutations, which trigger 
severe cardiac channelopathies, demon-
strate the pivotal function of KCNE1 on 
cardiovascular physiology.6-8 The impli-
cation of that the remaining KCNE pep-
tides may contribute to the modulation of 
I
ks
 is now under intense investigation.9-13 
Besides K
V
7.1, KCNE members associate 
with other K+ channels. Thus, K
V
11.1 in 




Although many KCNE subunits share 
tissue expression with Shaker K+ channels 
(K
V
1) channels, KCNE interactions with 
K
V
1 channels have attracted little research.1 
Early in 1992, K
V
1.3 and KCNE1 were 
simultaneously cloned in human Jurkat 
T-cells.15 Ten years later, Grunnet et al. 





1.3 channels and their het-





1.3 biophysics were affected, 
K
V
1.1 membrane surface targeting was 
not altered.16 Later, Melman et al. (2004) 
described that KCNE1 co-immunoprecip-
itated with K
V
1.5, but no further research 
was undertaken.17 Recently, Abbot et al. 
(2008) demonstrated that kcne2-/- mice 
exhibit altered cardiac I
kslow
, identified an 
interaction between K
V
1.5 and KCNE2 
in murine ventricles and suggested a func-




In this context, our recent contribution 
unequivocally demonstrates molecular 
interactions between KCNE4 and K
V
1.3, 
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derived from the immune system. To that 
end, data from tissues and tumors, cell lines 
and cancer cell lines are shown in Figures 
1, 2 and 3, respectively. All KCNE1-5 
members have been detected in myeloid 
and lymphoid lineages. It is noteworthy 
that while KCNE1 expression increases 
in some cancers, KCNE2 and KCNE4 
decrease. Similarly, KCNE1 induction has 
also been detected in germinal tumors.28 
We have previously described the impor-
tance of K
V
1.3 during activation and pro-
liferation of macrophages.25,26 Although 
both processes augment K
V
1.3, the chan-
nel seems to play a dual role. Prolonged 
signaling during activation triggers apop-
tosis.29,30 Additionally, highly proliferative 
cells exhibit lower KCNE4 expression 





1.5 form heteromeric complexes to fine-
tune the immunitary response.23,26 The 
evidence that KCNE4 is also implicated,19 
the presence of KCNE1 in lymphocytes,15 
and its putative association to K
V
1.5,17 sug-
gest an unidentified role for KCNE pep-
tides in immunitary system physiology.
In fact, our recent study is not the first 
to describe the presence of the KCNEs 
in the immunitary system. KCNE1 was 
cloned in T-lymphocytes.15 Grunnet et 
al. (2003) found KCNE4 mRNA in lym-
phocytes.16 In addition, KCNEs mRNA 
expression has also been investigated 
in thymus.10,27 Here we recapitulate the 
information available about the expression 
of KCNE1-5 in different tissue arrays, all 
which impairs the trafficking and localiza-
tion of these channels.19 KCNE4 acts as an 
endogenous dominant-negative regulatory 
subunit. Further inhibitory mechanisms 
by KCNE4 have been observed. Grunnet 
et al. (2002) describe that KCNE4 abro-
gates K
V
7.1 currents.20 Later, George and 
coworkers (2008) postulate that KCNE4 
could form part of a K
V
7.1/KCNE1 het-
erocomplex, responsible for downregulat-
ing the I
ks
 current.10 Furthermore, KCNE4 
also inhibits the calcium-activated K+ 
channel (K
Ca




Although limited, the immunitary sys-
tem has a defined repertoire of K+ channel 







β regulatory subunits.23-25 
Figure 1. Human KCne expression in healthy and cancer tissues. Affymetrix GeneChips HG-u95A-e (Genenote, http://bioinfo2.weizmann.ac.il/
cgi-bin/genenote/home_page.pl) and HG-u133A (GnF, (http://biogps.gnf.org) normalized as described in GeneCard (http://www.genecards.org). Black 
columns: healthy tissue (Genenote); Grey columns: healthy tissues (GnF); White columns: cancer samples (GnF).
Figure 2. KCne expression in human leukocytic cell lines. Array data from GnF BioGPS (http://biogps.gnf.org) normalized according to Su et al.31 
Legend: Cd34, bone marrow Cd34+ progenitors; Cd105, endothelial; X212, B lymphoblasts; Cd19, B cells; BdCA4, dendritic cells; Cd8, Cd8+ t-
cells; Cd4, Cd4+ t-cells; Cd56, nK cells; Cd33, myeloid; Cd14, monocytes.
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than their counterparts do (Fig. 1). 
During an insult, K
V
1.3 is activated and 
sustained activation triggers cell death. 
The persistence of activated macrophages 
during inflammation leads to disease. In 
this scenario, KCNE4 would exert an 
inhibitory effect not needed in prolifera-
tion. Accordingly, it is worth noting that 
during proliferation, most cells become 
resistant to apoptosis.
Evidence demonstrates that KCNE 
subunits are present in the immune sys-
tem and may interact with K
V
1 channels. 
Therefore, we suggest that KCNE sub-
units may play a yet undiscovered role in 
the immune system via associations with 
leukocyte K+ channels. These new interac-
tions situate KCNE, specifically KCNE4, 
as novel targets for immunomodulation. 
Further research should be undertaken to 
shed some light on this new issue.
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